Table 1. Clinical backgrounds of patients.
| n = 88 | |
|---|---|
| Age | 69.3±12.0 |
| Gender male/female | 57(65%)/31(35%) |
| Child Pugh grade B/C | 52(61%)/34(39%) |
| Etiology of cirrhosis(HCV/HBV/ALD/others) | 47/3/22/16 |
| Co-exsisting of HCC | 40(45.5%) |
| Furosemide (mg/day) | 20(0–100) |
| Spironolactone (mg/day) | 50(0–100) |
| Prior history of albumin infusion | 22(25%) |
| Prior history of paracentesis | 18(21%) |
| Albumin (g/dL) | 2.6±0.6 |
| Total bilirubin (mg/dL) | 1.6±1.1 |
| ALT (IU/L) | 32.7±30.2 |
| Creatinin (mg/dL) | 1.06±0.81 |
| eGFR (mg/min/1.73m2) | 65.0±28.6 |
| Serum Na (mEq/L) | 136.6±4.8 |
| Platelet counts (×104/μL) | 10.0±6.0 |
| Prothrombin activity (%) | 71.7±19.3 |
| CRP (mg/dL) | 1.14±1.38 |
| Urine osmolarity (mOsm/L) | 394±124 |
| Urine Na (mEq/L) | 67.6±31.7 |
| Urine K (mEq/L) | 23.0±12.2 |
| Urine Na/K | 3.67±2.34 |
Values are mean ± standard deviation or median (range)
HCV: hepatitis C virus, HBV: hepatitis B virus, ALD: alcoholic liver disease, HCC: hepatocellular carcinoma, ALT: alanine aminotransferase